Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley M Lemon

Showing results (131-140 of 203) with videos related to

Pageof 21
Sort By:
Antiviral Therapy|May 25, 2016
Primer ID ultra-deep sequencing reveals dynamics of drug resistance-associated variants in breakthrough hepatitis C viruses: relevance to treatment outcome and resistance screeningRichard Barnard, Abha Chopra, Ian James, et al.
Antiviral Research|March 21, 2025
Hepato-selective dihydroquinolizinones active against hepatitis A virus in vitro and in vivoIchiro Misumi, Zhizhou Yue, Zhengyuan Jiang, et al.
The Journal of Biological Chemistry|April 30, 2008
A locking mechanism regulates RNA synthesis and host protein interaction by the hepatitis C virus polymeraseSreedhar Chinnaswamy, Ian Yarbrough, Satheesh Palaninathan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2005
Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIFKui Li, Eileen Foy, Josephine C Ferreon, et al.
Nature|April 2, 2013
A pathogenic picornavirus acquires an envelope by hijacking cellular membranesZongdi Feng, Lucinda Hensley, Kevin L McKnight, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2024
"PROTAC" modified dihydroquinolizinones (DHQs) that cause degradation of PAPD-5 and inhibition of hepatitis A virus and hepatitis B virus, in vitroYou Li, Nicky Hwang, Andrew Snedeker, et al.
Plos Pathogens|May 11, 2026
Host species-specific mutations in the thumb domain of the 3Dpol polymerase are required for efficient replication of human hepatitis A virus in miceIchiro Misumi, Takayoshi Shirasaki, Ling Xie, et al.
Journal of Gastroenterology|May 16, 2006
Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen speciesYuichi Hara, Keisuke Hino, Michiari Okuda, et al.
Scientific Reports|April 16, 2014
The acyclic retinoid Peretinoin inhibits hepatitis C virus replication and infectious virus release in vitroTetsuro Shimakami, Masao Honda, Takayoshi Shirasaki, et al.
Antiviral Research|August 14, 2010
Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodiesMeital Gal-Tanamy, Romy Zemel, Larissa Bachmatov, et al.
Pageof 21

Showing results (131-140 of 203) with videos related to

Sort By:
Pageof 21
Antiviral Therapy|May 25, 2016
Primer ID ultra-deep sequencing reveals dynamics of drug resistance-associated variants in breakthrough hepatitis C viruses: relevance to treatment outcome and resistance screeningRichard Barnard, Abha Chopra, Ian James, et al.
Antiviral Research|March 21, 2025
Hepato-selective dihydroquinolizinones active against hepatitis A virus in vitro and in vivoIchiro Misumi, Zhizhou Yue, Zhengyuan Jiang, et al.
The Journal of Biological Chemistry|April 30, 2008
A locking mechanism regulates RNA synthesis and host protein interaction by the hepatitis C virus polymeraseSreedhar Chinnaswamy, Ian Yarbrough, Satheesh Palaninathan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2005
Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIFKui Li, Eileen Foy, Josephine C Ferreon, et al.
Nature|April 2, 2013
A pathogenic picornavirus acquires an envelope by hijacking cellular membranesZongdi Feng, Lucinda Hensley, Kevin L McKnight, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2024
"PROTAC" modified dihydroquinolizinones (DHQs) that cause degradation of PAPD-5 and inhibition of hepatitis A virus and hepatitis B virus, in vitroYou Li, Nicky Hwang, Andrew Snedeker, et al.
Plos Pathogens|May 11, 2026
Host species-specific mutations in the thumb domain of the 3Dpol polymerase are required for efficient replication of human hepatitis A virus in miceIchiro Misumi, Takayoshi Shirasaki, Ling Xie, et al.
Journal of Gastroenterology|May 16, 2006
Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen speciesYuichi Hara, Keisuke Hino, Michiari Okuda, et al.
Scientific Reports|April 16, 2014
The acyclic retinoid Peretinoin inhibits hepatitis C virus replication and infectious virus release in vitroTetsuro Shimakami, Masao Honda, Takayoshi Shirasaki, et al.
Antiviral Research|August 14, 2010
Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodiesMeital Gal-Tanamy, Romy Zemel, Larissa Bachmatov, et al.
Pageof 21